Shoulder Innovations Raises $75 Million in Initial Public Offering (IPO)
Shoulder Innovations, a commercial-stage medical technology company, has priced its initial public offering (IPO) of 5 million shares at $15.00 per share, raising approximately $75 million in gross proceeds. The company's common stock is expected to begin trading on the New York Stock Exchange under the ticker symbol 'SI' on July 31, 2025. Gilde Healthcare led the Series D financing of Shoulder Innovations in March 2023 and is excited to see the impact of the company's products on patient lives and outcomes.
Key Takeaways:
- Shoulder Innovations, a commercial-stage medical technology company, has raised $75 million in its initial public offering (IPO) of 5 million shares priced at $15.00 per share.
- The company's common stock is expected to begin trading on the New York Stock Exchange under the ticker symbol 'SI' on July 31, 2025.
- Gilde Healthcare led the Series D financing of Shoulder Innovations in March 2023 and is a part of the company's story.
- The company's products aim to transform the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.
- Shoulder Innovations' ecosystem includes advanced implant systems for shoulder arthroplasty, enabling technologies, efficient instrument systems, and specialized support and surgeon-to-surgeon collaboration.
- The company is committed to addressing the long-standing clinical and operational challenges in the shoulder surgical care market.
Statistics:
- Gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Shoulder Innovations, are expected to be approximately $75.0 million.
- The company has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price less underwriting discounts and commissions.
- Shoulder Innovations' common stock is expected to begin trading on the New York Stock Exchange under the ticker symbol 'SI' on July 31, 2025.
- The offering is expected to close on August 1, 2025, subject to satisfaction of customary closing conditions.
Sources:
- Gilde Healthcare: [www.gildehealthcare.com]